Development and validation of a clinically applicable biomarker panel for identifying autoimmune type IIb chronic spontaneous urticaria.

Authors

Jiang Ji, Lu Chen, Ni Ma, Yuxu Yao, Chuqiao Zhang, Enze Li, Qingqing Jiao

Published in

The World Allergy Organization journal. Volume 19. Issue 10. Pages 101466. Epub Sep 24, 2026.

Abstract

Chronic spontaneous urticaria (CSU) includes 2 autoimmune endotypes, type I (autoallergic) and type IIb (autoimmune), which differ in pathogenesis and treatment response. However, practical criteria for distinguishing these endotypes in routine clinical practice remain limited.
This study aimed to evaluate whether combinations of readily available clinical parameters facilitate identification of probable type IIb CSU.
A total of 125 CSU patients were evaluated using 3 diagnostic combinations: (1) high IgG anti-thyroid peroxidase antibodies (IgG-anti-TPO) with low total IgE; (2) high IgG-anti-TPO with a positive autologous serum skin test (ASST+); and (3) low total IgE with ASST+. Clinical and laboratory features were compared between presumed endotypes. Serum cytokine profiles were analyzed and validated in an independent cohort of 40 patients. A predictive graphical model integrating clinical and laboratory variables was developed.
All 3 combinations identified patient subsets with features compatible with type IIb CSU, including trends toward higher disease activity (UAS7), peripheral eosinopenia and basopenia. The combination of high IgG-anti-TPO with ASST positivity was associated with the most comprehensive type IIb-compatible features. Cytokine profiles also differed between endotypes: serum IL-6 tended to be lower in possible type IIb CSU, whereas IL-17 A and TNF-α tended to be higher, compared with the remaining CSU patients. These patterns were directionally supported in the independent validation cohort. The predictive nomogram model demonstrated good discriminatory performance.
Combinations of IgG-anti-TPO, total IgE, and ASST provide practical reference tools for identifying probable type IIb CSU, with high IgG-anti-TPO plus ASST positivity showing the highest clinical relevance. Distinct cytokine patterns further support endotype-related immune differences and may aid individualized management.

PMID:
42831033
Bibliographic data and abstract were imported from PubMed on 05 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.